Spark Investment Management’s Solid Biosciences SLDB Stock Holding History

Spark Investment Management’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,265	Closed	-$188K	–	239
2020 Q1	$188K	Sell	5,265 -3,988	-43%	-$197K	0.1%	235
2019 Q4	$617K	Buy	9,253 +5,377	+139%	+$593K	0.07%	317
2019 Q3	$601K	Sell	3,876 -10,543	-73%	-$1.19M	0.08%	233
2019 Q2	$1.24M	Sell	14,419 -6,788	-32%	-$740K	0.09%	272
2019 Q1	$2.93M	Buy	21,207 +9,343	+79%	+$2.34M	0.14%	199
2018 Q4	$4.77M	Buy	11,864 +3,444	+41%	+$1.62M	0.33%	97
2018 Q3	$5.96M	Buy	8,420 +4,154	+97%	+$2.61M	0.34%	83
2018 Q2	$2.28M	Buy	+4,266	New	+$1.31M	0.13%	224

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Spark Investment Management's SLDB Position: Q2 2020 in Review

Spark Investment Management sold out of Solid Biosciences (SLDB) in Q2 2020, closing a stake of 5,265 shares — an estimated $188K sold.

Spark Investment Management first reported a position in SLDB in Q2 2018 and held it in 8 quarters. The position peaked at $5.96M in Q3 2018. 66 funds tracked by Wall St. Rank hold SLDB as of Q2 2020.

Spark Investment Management reported no remaining Solid Biosciences position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 5,265 Solid Biosciences shares in Q2 2020, an estimated $188K.
Spark Investment Management first reported a position in Solid Biosciences in Q2 2018 and held it in 8 quarters.
Spark Investment Management's Solid Biosciences position peaked at $5.96M in Q3 2018.
66 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.